PatientsVille.com LogoHalaven Side Effects

How can Halaven Side Effects affect You? | PatientsVille.com

View and Submit Halaven Side Effects

Your Halaven Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.

>>Compare Halaven side effects | View FDA-reported Halaven side effects

View and Report Halaven Side Effects Click Check Boxes Below to Submit a Side Effect or Use a Link for Additional Health Information
Tachycardia (1)
>>View All User Submitted Halaven Side Effects

Halaven Side Effects and Adverse Effects reported to US Food and Drug Administration (FDA)

Spread the word: Share, Email, Print

  Showing 101-125 of 165 

Interstitial Lung Disease (7955049-9)
on Nov 22, 2011 Female from JAPAN , 50 years of age, was diagnosed with
  • breast cancer recurrent
and was treated with Halaven. Directly after, patient experienced the unwanted or unexpected Halaven side effects: interstitial lung disease. Halaven dosage: N/A. Patient was hospitalized.

Hepatic Cirrhosis (7954737-8)
Patient was taking Halaven. Patient felt the following Halaven side effects: hepatic cirrhosis on Nov 23, 2011 from GERMANY Additional patient health information: Female , 46 years of age, was diagnosed with
  • breast cancer
and. Halaven dosage: N/A.

Fatigue, Interstitial Lung Disease, Thrombotic Thrombocytopenic Purpura (7954330-7)
Adverse event was reported on Nov 22, 2011 by a Female taking Halaven (Dosage: N/A) was diagnosed with
  • breast cancer recurrent
and. Location: JAPAN , 50 years of age, After Halaven was administered, patient encountered several Halaven side effects: fatigue, interstitial lung disease, thrombotic thrombocytopenic purpura. Patient was hospitalized.

Malaise, Neutropenia, Anaemia, Lymphopenia, Febrile Neutropenia, Leukopenia, Pneumonia (7954268-5)
on Nov 21, 2011 Female from JAPAN , 52 years of age, weighting 114.6 lb, was treated with Halaven. Directly after, patient experienced the unwanted or unexpected Halaven side effects: malaise, neutropenia, anaemia, lymphopenia, febrile neutropenia, leukopenia, pneumonia. Halaven dosage: N/A. Patient was hospitalized.


Neoplasm Malignant, Bacteraemia (7950046-1)
on Nov 09, 2011 Female from SPAIN , 48 years of age, was treated with Halaven. Patient felt the following Halaven side effects: neoplasm malignant, bacteraemia. Halaven dosage: N/A.

Hepatic Failure (7941818-8)
Patient was taking Halaven. After Halaven was administered, patient encountered several Halaven side effects: hepatic failure on Nov 14, 2011 from JAPAN Additional patient health information: Female , 66 years of age, was diagnosed with
  • metastases to liver
and. Halaven dosage: N/A.

Leukopenia, Febrile Neutropenia, C-reactive Protein Increased (7930913-5)
Adverse event was reported on Nov 10, 2011 by a Female taking Halaven (Dosage: N/A) . Location: JAPAN , weighting 127.9 lb, Directly after, patient experienced the unwanted or unexpected Halaven side effects: leukopenia, febrile neutropenia, c-reactive protein increased.
Associated medications used:
  • Loxonin
Patient was hospitalized.

Pain, Feeling Hot, Headache (7928220-X)
on Nov 07, 2011 Female from JAPAN , weighting 103.6 lb, was diagnosed with
  • breast cancer recurrent
  • metastases to lymph nodes
  • stomatitis
  • metastases to lung
and was treated with Halaven. Patient felt the following Halaven side effects: pain, feeling hot, headache. Halaven dosage: N/A. Patient was hospitalized.

Pyrexia, Sepsis (7927620-1)
on Nov 08, 2011 Female from CANADA , weighting 154.3 lb, was treated with Halaven. After Halaven was administered, patient encountered several Halaven side effects: pyrexia, sepsis. Halaven dosage: N/A.

Cerebrovascular Accident (7912611-7)
Patient was taking Halaven. Directly after, patient experienced the unwanted or unexpected Halaven side effects: cerebrovascular accident on Nov 03, 2011 from UNITED KINGDOM Additional patient health information: Female , 70 years of age, weighting 165.3 lb, . Halaven dosage: N/A.

Pyrexia, Rash, Toxic Epidermal Necrolysis (7910211-6)
Adverse event was reported on Nov 01, 2011 by a Female taking Halaven (Dosage: N/A) . Location: UNITED KINGDOM , weighting 165.3 lb, Patient felt the following Halaven side effects: pyrexia, rash, toxic epidermal necrolysis.
Multiple prescriptions taken:
  • Phenytoin
  • Acetaminophen
Patient was hospitalized.

Neutropenia, Sensation Of Heaviness, Stomatitis, Neuropathy Peripheral, Pleural Effusion (7909270-6)
on Nov 04, 2011 Female from JAPAN , 67 years of age, was diagnosed with
  • breast cancer recurrent
and was treated with Halaven. After Halaven was administered, patient encountered several Halaven side effects: neutropenia, sensation of heaviness, stomatitis, neuropathy peripheral, pleural effusion. Halaven dosage: N/A. Patient was hospitalized.

Fatigue, Thrombotic Thrombocytopenic Purpura, Interstitial Lung Disease (7906387-7)
on Nov 01, 2011 Female from JAPAN , 50 years of age, was diagnosed with
  • breast cancer recurrent
and was treated with Halaven. Directly after, patient experienced the unwanted or unexpected Halaven side effects: fatigue, thrombotic thrombocytopenic purpura, interstitial lung disease. Halaven dosage: N/A. Patient was hospitalized.

Toxic Epidermal Necrolysis, Pyrexia, Herpes Zoster Disseminated, Rash (7901790-3)
Patient was taking Halaven. Patient felt the following Halaven side effects: toxic epidermal necrolysis, pyrexia, herpes zoster disseminated, rash on Nov 08, 2011 from UNITED KINGDOM Additional patient health information: Female , 42 years of age, weighting 165.3 lb, was diagnosed with
  • breast cancer metastatic
and. Halaven dosage: Unk.
Multiple prescriptions taken:
  • Paracetamol
  • Phenytoin (Unk)
Patient was hospitalized.

Respiratory Failure (7897596-4)
Adverse event was reported on Oct 28, 2011 by a Female taking Halaven (Dosage: N/A) was diagnosed with
  • breast cancer recurrent
  • metastases to lung
  • metastases to lymph nodes
  • metastases to bone
and. Location: JAPAN , 58 years of age, weighting 112.4 lb, After Halaven was administered, patient encountered several Halaven side effects: respiratory failure.

Interstitial Lung Disease (7893154-6)
on Oct 27, 2011 Female from JAPAN , weighting 85.98 lb, was diagnosed with
  • recurrent cancer
and was treated with Halaven. Directly after, patient experienced the unwanted or unexpected Halaven side effects: interstitial lung disease. Halaven dosage: N/A.
Associated medications used:
  • Gemzar
  • Dextromethorphan Hydrobromide
Patient was hospitalized.

Extravasation (7892711-0)
on Oct 25, 2011 Female from UNITED STATES , 63 years of age, weighting 233.7 lb, was treated with Halaven. Patient felt the following Halaven side effects: extravasation. Halaven dosage: N/A.

Febrile Neutropenia (7892587-1)
Patient was taking Halaven. After Halaven was administered, patient encountered several Halaven side effects: febrile neutropenia on Oct 27, 2011 from JAPAN Additional patient health information: Female , 63 years of age, was diagnosed with
  • breast cancer recurrent
and. Halaven dosage: N/A.
Multiple concurrent drugs taken:
  • Herceptin
  • Tykerb
Patient was hospitalized.

Interstitial Lung Disease, Leukopenia, Thrombocytopenia (7892554-8)
Adverse event was reported on Oct 24, 2011 by a Female taking Halaven (Dosage: N/A) was diagnosed with
  • metastases to bone
and. Location: JAPAN , weighting 136.7 lb, Directly after, patient experienced the unwanted or unexpected Halaven side effects: interstitial lung disease, leukopenia, thrombocytopenia.
Associated medications used:
  • Lasix
Patient was hospitalized.

Rash, Herpes Zoster Disseminated, Body Temperature Increased, Toxic Epidermal Necrolysis (7888371-5)
on Oct 31, 2011 Female from UNITED KINGDOM , 42 years of age, was diagnosed with
  • breast cancer metastatic
and was treated with Halaven. Patient felt the following Halaven side effects: rash, herpes zoster disseminated, body temperature increased, toxic epidermal necrolysis. Halaven dosage: Unk.
Multiple prescriptions taken:
  • Phenytoin (Unk)
Patient was hospitalized.

Diarrhoea, Dehydration (7884990-0)
on Oct 24, 2011 Male from JAPAN , 56 years of age, was diagnosed with
  • breast cancer recurrent
and was treated with Halaven. After Halaven was administered, patient encountered several Halaven side effects: diarrhoea, dehydration. Halaven dosage: N/A. Patient was hospitalized.

Pleural Effusion (7884707-X)
Patient was taking Halaven. Directly after, patient experienced the unwanted or unexpected Halaven side effects: pleural effusion on Oct 24, 2011 from JAPAN Additional patient health information: Female , weighting 119.0 lb, was diagnosed with
  • breast cancer recurrent
and. Halaven dosage: N/A. Patient was hospitalized.

Thrombotic Thrombocytopenic Purpura, Interstitial Lung Disease, Fatigue (7831148-7)
Adverse event was reported on Oct 11, 2011 by a Female taking Halaven (Dosage: N/A) was diagnosed with
  • breast cancer recurrent
and. Location: JAPAN , 50 years of age, Patient felt the following Halaven side effects: thrombotic thrombocytopenic purpura, interstitial lung disease, fatigue. Patient was hospitalized.

Renal Failure (7830715-4)
on Oct 10, 2011 Female from UNITED STATES , 66 years of age, was diagnosed with
  • breast cancer
and was treated with Halaven. After Halaven was administered, patient encountered several Halaven side effects: renal failure. Halaven dosage: N/A.

Pleural Effusion, Neoplasm Malignant (7824617-7)
on Oct 07, 2011 Female from JAPAN , 46 years of age, weighting 110.2 lb, was diagnosed with
  • metastases to lung
  • metastases to liver
  • breast cancer
  • metastases to bone
and was treated with Halaven. Directly after, patient experienced the unwanted or unexpected Halaven side effects: pleural effusion, neoplasm malignant. Halaven dosage: N/A. Patient was hospitalized.

  Showing 101-125 of 165 

Halaven Health Episodes

Discuss Halaven Side Effects

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Halaven Information

Alternative HALAVEN Names:ERIBULIN

Active Ingredient: ERIBULIN

More About Halaven

Side Effects reported to FDA: 165. View Halaven Adverse Reports

Halaven safety alerts: No

Reported deaths: 38

Reported hospitalizations: 112

Managing Your Medicines

Tips for Taking Medicines Properly

Before Taking Halaven

Find Out How to Take Halaven

Did You Have a Halaven Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Halaven for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective